Finance

Lists
ALC:NYSE
Alcon AG
၆၃.၁၉ US$
-၁.၇၉%
(-၁.၁၅) 1D
၆၂.၈၁ US$
-၀.၆၀% (-၀.၃၈)
After hours
Closed: အောက် ၆, GMT-၄ ၁၆:၀၀:၀၈  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ALC...
Open
၆၄.၁၆ US$
High
၆၄.၁၉ US$
Low
၆၂.၉၉ US$
Mkt. cap
ဋေ ၂.၆၃ ထ
Avg. vol.
၁.၅၇ သန်း
Volume
၂.၃၉ သန်း
52-wk high
၈၇.၆၄ US$
52-wk low
၆၁.၈၄ US$
Beta
၀.၈၈
Shares outstanding
၄၈.၃၄ ကုဋေ
No. of employees
၂ သောင်း
Open
၆၄.၁၆ US$
High
၆၄.၁၉ US$
Low
၆၂.၉၉ US$
Mkt. cap
ဋေ ၂.၆၃ ထ
Avg. vol.
၁.၅၇ သန်း
Volume
၂.၃၉ သန်း
52-wk high
၈၇.၆၄ US$
52-wk low
၆၁.၈၄ US$
Beta
၀.၈၈
Shares outstanding
၄၈.၃၄ ကုဋေ
No. of employees
၂ သောင်း
News stories
From web sources and news partners
AD HOC NEWS
AD HOC NEWS
·
ပြီးခဲ့သည့် ၁ ရက်
Alcon stock after-hours at EUR 57.18: plus 1.08 percent versus prior close
AD HOC NEWS
AD HOC NEWS
·
ပြီးခဲ့သည့် ၁ ရက်
Alcon stock gets a new weekly lens launch in October 2026
AD HOC NEWS
AD HOC NEWS
·
ပြီးခဲ့သည့် ၁ ရက်
Alcon announces Academy research. Alcon stock sits 23.02 percent below its 52-week high
AD HOC NEWS
AD HOC NEWS
·
ပြီးခဲ့သည့် ၁ ရက်
Alcon stock pre-market at EUR 56.31: minus 0.46 percent
Profile
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people. Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
About Alcon AG
CEODavid J. Endicott
Employees၂.၅ သောင်း
Founded၁၉၄၅
Headquartersဂျနီဗာမြို့, Geneva, ဆွစ်ဇာလန်
Sector-
Websitealcon.com
Analyst
Recommendation
Action
Price target
Projected
Date
No analyst ratings found.
Last report
၂၀၂၆ ဩ ၁၁
Fiscal period
Q2 2026
EPS / Est. (USD)
၀.၈၄ US$ / ၀.၇၅ US$
+၁၁.၃၄%beat
Revenue / Est. (USD)
၂၈၂.၃၀ ဋေ / ၂၇၆.၈၄ ဋေ
+၁.၉၇%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
၂၆၁.၄၀ ဋေ
၂၇၁.၈၀ ဋေ
၂၇၀.၆၀ ဋေ
၂၈၂.၃၀ ဋေ
Cost of goods sold
၁၁၅.၆၀ ဋေ
၁၂၀.၀၀ ဋေ
၁၁၄.၃၀ ဋေ
၁၁၄.၈၀ ဋေ
Cost of revenue
၁၁၅.၆၀ ဋေ
၁၂၀.၀၀ ဋေ
၁၁၄.၃၀ ဋေ
၁၁၄.၈၀ ဋေ
Research and development expenses
၂၄.၈၀ ကုဋေ
၂၇.၃၀ ကုဋေ
၂၄.၅၀ ကုဋေ
၂၆.၁၀ ကုဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၈၆.၅၀ ကုဋေ
၉၀.၁၀ ကုဋေ
၈၈.၂၀ ကုဋေ
၉၆.၄၀ ကုဋေ
Operating expense
၁၁၂.၂၀ ဋေ
၁၂၀.၀၀ ဋေ
၁၂၃.၃၀ ဋေ
၁၂၆.၂၀ ဋေ
Total operating expenses
၂၂၇.၈၀ ဋေ
၂၄၀.၀၀ ဋေ
၂၃၇.၆၀ ဋေ
၂၄၁.၀၀ ဋေ
Operating income
၃၃.၆၀ ကုဋေ
၃၁.၈၀ ကုဋေ
၃၃.၀၀ ကုဋေ
၄၁.၃၀ ကုဋေ
Other non operating income
၃.၀၀ သန်း
-၂.၈၀ ကုဋေ
-
-
EBT including unusual items
၂၈.၃၀ ကုဋေ
၂၆.၄၀ ကုဋေ
၂၄.၀၀ ကုဋေ
-၄.၆၀ ကုဋေ
EBT excluding unusual items
၂၈.၇၀ ကုဋေ
၂၇.၁၀ ကုဋေ
၂၇.၈၀ ကုဋေ
၃၅.၆၀ ကုဋေ
Income tax expense
၄.၆၀ ကုဋေ
၄.၇၀ ကုဋေ
၅.၁၀ ကုဋေ
-၄.၆၀ ကုဋေ
Effective tax rate
၁၆.၂၅%
၁၇.၈၀%
၂၁.၂၅%
၁၀၀.၀၀%
Other operating expenses
၉.၀၀ သန်း
၂.၆၀ ကုဋေ
၁၀.၆၀ ကုဋေ
၃.၇၀ ကုဋေ
Net income
၂၃.၇၀ ကုဋေ
၂၁.၇၀ ကုဋေ
၁၈.၉၀ ကုဋေ
-
Net profit margin
၉.၀၇%
၇.၉၈%
၆.၉၈%
-
Earnings per share
၀.၇၉
၀.၇၈
၀.၈၅
၀.၈၄
Interest and investment income
-
၇.၄၀ ကုဋေ
၂.၀၀ သန်း
-
Interest expense
-၅.၁၀ ကုဋေ
-၅.၃၀ ကုဋေ
-၅.၂၀ ကုဋေ
-၅.၃၀ ကုဋေ
Net interest expenses
-၅.၁၀ ကုဋေ
၂.၁၀ ကုဋေ
-၅.၀၀ ကုဋေ
-၅.၃၀ ကုဋေ
Depreciation and amortization charges
-
-
-
-
EBITDA
၇၈.၄၀ ကုဋေ
၄၄.၁၀ ကုဋေ
၆၀.၀၀ ကုဋေ
၆၇.၆၀ ကုဋေ
Gain or loss from assets sale
၅.၀၀ သန်း
၉.၀၀ သန်း
၂.၀၀ သန်း
၂.၀၀ သန်း
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google အက်ပ်များ